OBJECTIVE: To determine the incidence of immunoglobulin light chain amyloidosis (AL amyloidosis) in a strictly defined geographic area from 1990 through 2015. PATIENTS AND METHODS: We searched a computerized database for the records of all Olmsted County, Minnesota, residents with a diagnosis of AL amyloidosis from January 1, 1990, through December 31, 2015. In addition, records of all residents with a mention of amyloidosis were obtained from the Rochester Epidemiology Project, which contains the medical records of Mayo Clinic and Olmsted Medical Group. The diagnosis of AL amyloidosis was determined by mass spectrometry, immunohistochemical analysis, or positive Congo red staining. RESULTS: Thirty-five patients were identified as having AL amyloidosis. The median age at diagnosis was 76 years (range, 38-90 years), with men accounting for 54%. The incidence rate of AL amyloidosis from 1990 through 2015 adjusted for age and sex was 1.2 per 100,000 person-years (95% CI, 0.8-1.6 per 100,000 person-years). Rates were similar across the decades 1990-1999, 2000-2009, and 2010-2015 at 1.1, 0.9, and 1.6 per 100,000 person-years, respectively, with no suggestion of an increasing rate during the 26 years. There was a trend toward an increasing incidence over time from 1950 through 2015 in Olmsted County, but it was not significant (P=.15). Applying the rate of 1.2 per 100,000 person-years to the US population of 321 million in 2015, one would expect 3852 new cases of AL amyloidosis in the United States each year. CONCLUSION: The incidence of AL amyloidosis in Olmsted County has not changed significantly in the past 66 years.
OBJECTIVE: To determine the incidence of immunoglobulin light chain amyloidosis (AL amyloidosis) in a strictly defined geographic area from 1990 through 2015. PATIENTS AND METHODS: We searched a computerized database for the records of all Olmsted County, Minnesota, residents with a diagnosis of AL amyloidosis from January 1, 1990, through December 31, 2015. In addition, records of all residents with a mention of amyloidosis were obtained from the Rochester Epidemiology Project, which contains the medical records of Mayo Clinic and Olmsted Medical Group. The diagnosis of AL amyloidosis was determined by mass spectrometry, immunohistochemical analysis, or positive Congo red staining. RESULTS: Thirty-five patients were identified as having AL amyloidosis. The median age at diagnosis was 76 years (range, 38-90 years), with men accounting for 54%. The incidence rate of AL amyloidosis from 1990 through 2015 adjusted for age and sex was 1.2 per 100,000 person-years (95% CI, 0.8-1.6 per 100,000 person-years). Rates were similar across the decades 1990-1999, 2000-2009, and 2010-2015 at 1.1, 0.9, and 1.6 per 100,000 person-years, respectively, with no suggestion of an increasing rate during the 26 years. There was a trend toward an increasing incidence over time from 1950 through 2015 in Olmsted County, but it was not significant (P=.15). Applying the rate of 1.2 per 100,000 person-years to the US population of 321 million in 2015, one would expect 3852 new cases of AL amyloidosis in the United States each year. CONCLUSION: The incidence of AL amyloidosis in Olmsted County has not changed significantly in the past 66 years.
Authors: Jean D Sipe; Merrill D Benson; Joel N Buxbaum; Shu-Ichi Ikeda; Giampaolo Merlini; Maria J M Saraiva; Per Westermark Journal: Amyloid Date: 2016-11-24 Impact factor: 7.141
Authors: Robert A Kyle; Terry M Therneau; S Vincent Rajkumar; Dirk R Larson; Matthew F Plevak; L Joseph Melton Journal: Cancer Date: 2004-12-01 Impact factor: 6.860
Authors: Julie A Vrana; Jason D Theis; Surendra Dasari; Oana M Mereuta; Angela Dispenzieri; Steven R Zeldenrust; Morie A Gertz; Paul J Kurtin; Karen L Grogg; Ahmet Dogan Journal: Haematologica Date: 2014-04-18 Impact factor: 9.941
Authors: Julie A Vrana; Jeffrey D Gamez; Benjamin J Madden; Jason D Theis; H Robert Bergen; Ahmet Dogan Journal: Blood Date: 2009-10-01 Impact factor: 22.113
Authors: Walter A Rocca; Barbara P Yawn; Jennifer L St Sauver; Brandon R Grossardt; L Joseph Melton Journal: Mayo Clin Proc Date: 2012-11-28 Impact factor: 7.616
Authors: Alissa Visram; Abdullah S Al Saleh; Harsh Parmar; Jennifer S McDonald; John C Lieske; Iuliana Vaxman; Eli Muchtar; Miriam Hobbs; Amie Fonder; Yi L Hwa; Francis K Buadi; David Dingli; Martha Q Lacy; Angela Dispenzieri; Prashant Kapoor; Suzanne R Hayman; Rahma Warsame; Taxiarchis V Kourelis; Mustaqeem Siddiqui; Wilson I Gonsalves; John A Lust; Robert A Kyle; S Vincent Rajkumar; Morie A Gertz; Shaji K Kumar; Nelson Leung Journal: Blood Cancer J Date: 2020-12-11 Impact factor: 11.037
Authors: Andrew Staron; Lawreen H Connors; Luke Zheng; Gheorghe Doros; Vaishali Sanchorawala Journal: Blood Cancer J Date: 2020-11-10 Impact factor: 11.037
Authors: Andrew Staron; Luke Zheng; Gheorghe Doros; Lawreen H Connors; Lisa M Mendelson; Tracy Joshi; Vaishali Sanchorawala Journal: Blood Cancer J Date: 2021-08-04 Impact factor: 11.037